ACG Clinical Guideline: Ulcerative Colitis in Adults

被引:1162
作者
Rubin, David T. [1 ]
Ananthakrishnan, Ashwin N. [2 ]
Siegel, Corey A. [3 ]
Sauer, Bryan G. [4 ]
Long, Millie D. [5 ]
机构
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL 60637 USA
[2] Massachusetts Gen Hosp, Crohns & Colitis Ctr, Div Gastroenterol, Boston, MA 02114 USA
[3] Dartmouth Hitchcock Med Ctr, Sect Gastroenterol & Hepatol, Lebanon, NH 03766 USA
[4] Univ Virginia, Dept Med, Charlottesville, VA USA
[5] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA
关键词
INFLAMMATORY-BOWEL-DISEASE; C-REACTIVE PROTEIN; CLOSTRIDIUM-DIFFICILE INFECTION; TERM-FOLLOW-UP; FECAL MICROBIOTA TRANSPLANTATION; RANDOMIZED CONTROLLED-TRIAL; REPORTED OUTCOME MEASURES; ORAL TACROLIMUS FK506; DOUBLE-BLIND; ENDOSCOPIC INDEX;
D O I
10.14309/ajg.0000000000000152
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) process. In instances where the evidence was not appropriate for GRADE, but there was consensus of significant clinical merit, key concept statements were developed using expert consensus. These guidelines are meant to be broadly applicable and should be viewed as the preferred, but not only, approach to clinical scenarios.
引用
收藏
页码:384 / 413
页数:30
相关论文
共 269 条
[91]  
Gallinger ZR, 2017, ENDOSC INT OPEN, V5, pE974, DOI 10.1055/s-0043-117944
[92]   Surgery in ulcerative colitis: When? How? [J].
Gallo, Gaetano ;
Kotze, Paulo Gustavo ;
Spinelli, Antonino .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2018, 32-33 :71-78
[93]   Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis [J].
Gisbert, J. P. ;
Linares, P. M. ;
McNicholl, A. G. ;
Mate, J. ;
Gomollon, F. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (02) :126-137
[94]   Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review [J].
Gisbert, Javier P. ;
Panes, Julian .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (03) :760-767
[95]   Does Rectal Sparing Ever Occur in Ulcerative Colitis? [J].
Glickman, Jonathan N. ;
Odze, Robert D. .
INFLAMMATORY BOWEL DISEASES, 2008, 14 :S166-S167
[96]   Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study [J].
Grainge, Matthew J. ;
West, Joe ;
Card, Timothy R. .
LANCET, 2010, 375 (9715) :657-663
[97]   Clinical trial: colectomy after rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study [J].
Gustavsson, A. ;
Jarnerot, G. ;
Hertervig, E. ;
Friis-Liby, I. ;
Blomquist, L. ;
Karlen, P. ;
Granno, C. ;
Vilien, M. ;
Strom, M. ;
Verbaan, H. ;
Hellstrom, P. M. ;
Magnuson, A. ;
Halfvarson, J. ;
Tysk, C. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (08) :984-989
[98]   GRADE guidelines: 7. Rating the quality of evidence-inconsistency [J].
Guyatt, Gordon H. ;
Oxman, Andrew D. ;
Kunz, Regina ;
Woodcock, James ;
Brozek, Jan ;
Helfand, Mark ;
Alonso-Coello, Pablo ;
Glasziou, Paul ;
Jaeschke, Roman ;
Akl, Elie A. ;
Norris, Susan ;
Vist, Gunn ;
Dahm, Philipp ;
Shukla, Vijay K. ;
Higgins, Julian ;
Falck-Ytter, Yngve ;
Schuenemann, Holger J. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (12) :1294-1302
[99]   Efficacy of infliximab in acute severe ulcerative colitis: A single-centre experience [J].
Halpin, Stephen J. ;
Hamlin, P. John ;
Greer, Daniel P. ;
Warren, Lisa ;
Ford, Alexander C. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) :1091-1097
[100]   Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease [J].
Hanada, Yuri ;
Khanna, Sahil ;
Loftus, Edward V., Jr. ;
Raffals, Laura E. ;
Pardi, Darrell S. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (04) :528-533